- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06838754
Effect of Whole Body Vibration on Down Syndrome
March 19, 2025 updated by: Riphah International University
Effects of Whole Body Vibration on Gait Parameters and Postural Control in Children With Down Syndrome
A congenital condition known as Down syndrome is typified by an excess of genetic material from chromosome 21, making 47 chromosomes in total.
Development of the body and brain may be impacted.
About 1 in 700-1100 live births have the condition, and 1 in 700-1100 live births inherit it.
Heart disease, hypotonia, ligament laxity, cerebral disabilities, thyroid abnormalities, and metabolic diseases are among the physical, cognitive, and metabolic changes that define it.
Reduced performance, increased energy consumption, and altered gait patterns are frequently the results of motor disorders.
This study intends to ascertain the effects of whole body vibrations (WBV), an activity that has been recommended for individuals with Down syndrome, on gait parameters and postural control in children with this condition.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Whole Body Vibration (WBV) and routine physical therapy (RPT) are given to Group A, whereas routine physical therapy is given to Group B as a control.
Two sessions of 20 minutes each are given to both groups twice a week.
Postural control and gait metrics are the outcomes that will be examined.
The present investigation will be conducted over a two-month period and will be a randomized control experiment.
Alkhidmat Hospital in Sargodha and Al-Ghafoor Hospital in Bhera will provide the data.
16 participants will participate in the trial; they will be randomly assigned to two equal groups.
Children with DS, ages 5 to 12, of both sexes, will be eligible to participate in the study.
The condition of improved comprehension of children older than five years was taken into consideration when determining the inclusion criteria.
Study Type
Interventional
Enrollment (Actual)
16
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Punjab
-
Lahore, Punjab, Pakistan, 54700
- Riphah International University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Ages 5-12
- Both sexes are chosen
- Children with Down syndrome older than 5 who are more knowledgeable about the exercise to be done are given preference.
Exclusion Criteria:
- Children with cardiac conditions and other conditions
- Atlantoaxial instability and prosthesis implantation are excluded.
- DS kids who don't have their parents or legal guardians sign the consent form.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Whole body vibration therapy
Experimental group will receive whole body vibrations while sitting.
Walking in all directions,
|
Experimental group will get whole body vibrations.
WBV will be performed by the patient while seated on the vibrating plate's base.
Five series with a 30-second wait will make up each session.
Five minutes and thirty seconds will be spent on vibration, and twenty minutes and thirty seconds will be spent on exercise.
5 Hz will be the frequency utilized.
Over the course of two months, 16 classes will be held twice a week.
|
|
Other: Routine physical therapy
Group B will be the only one performing routine physical therapy (RPT).
Stretching exercises will be part of these regular workouts.
Walking in all directions,
|
Group B will only get routine physical therapy.
Walking in all directions, advancing past the point of stability in a variety of positions, including half-kneeling, standing on both soft and hard surfaces, stepping up and down, walking and standing simultaneously, and standing on one leg with eyes open and closed were all part of the postural control exercise.
There will be a 20-minute session.As each participant's functional improvement progresses, the intensity of the workout program will progressively rise.
There will be 16 sessions in total (two days a week), with 8 sessions for each group.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Step length
Time Frame: 2 months.
|
Step length will be measured from consecutive heel contacts in cm.
|
2 months.
|
|
Posture and postural ability test (PPAS)
Time Frame: 2 months.
|
The PPAS assesses 4 positions.
Standing, sitting, supine and prone Each position is assessed according to the postural ability, quality of posture and within postural ability seven levels are designated, ranging from Level 1 = 'Unplaceable in an aligned posture' to 7 = Able to move into and out of position.
|
2 months.
|
|
Stride length
Time Frame: 2 months.
|
Stride length is the distance between the previous heel strike of the right foot and the new heel strike of the right foot and measured in cm.
|
2 months.
|
|
Step width
Time Frame: 2 months.
|
Step width will be measured from the mediolateral space between the two feet in cm.
|
2 months.
|
|
Foot angle
Time Frame: 2 months.
|
Foot angle will be measured by the angle between the line of progression and the foot axis in degree.
|
2 months.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Tuba Sameen, MS*, Riphah International University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 28, 2024
Primary Completion (Actual)
February 23, 2025
Study Completion (Actual)
March 7, 2025
Study Registration Dates
First Submitted
November 3, 2024
First Submitted That Met QC Criteria
February 20, 2025
First Posted (Actual)
March 25, 2025
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
March 19, 2025
Last Verified
March 1, 2025
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- REC/RCR & AHS/24/0716
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Down Syndrome
-
Rachel G. Greenberg, MD, MB, MHSEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsTerminatedHyperactivity in Children With Down Syndrome | Impulsivity in Children With Down SyndromeUnited States
-
Izgi Miray DemirbagRecruitingDown Syndrome (DS)Turkey (Türkiye)
-
Brigham and Women's HospitalNational Institutes of Health (NIH)Not yet recruitingDown Syndrome (DS)United States
-
University of Nevada, Las VegasRecruiting
-
Universidad de BurgosEuropean University Miguel de CervantesRecruiting
-
Aelis FarmaHospital del Mar Research Institute (IMIM)Enrolling by invitation
-
Sohag UniversityActive, not recruitingDown Syndrome | Cervical Spine Instability in Down SyndromeEgypt
-
Alnylam PharmaceuticalsNot yet recruitingDown Syndrome-Associated Alzheimer's Disease (DS-AD)United States
-
Riphah International UniversityCompletedDown S SyndromePakistan
-
Hoffmann-La RocheCompletedHealthy Volunteer, Down SyndromeUnited Kingdom
Clinical Trials on Whole body vibration therapy
-
Uludag UniversityNot yet recruiting
-
The Hong Kong Polytechnic UniversityCompleted
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityCompletedHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm | Chemotherapy-Induced Peripheral NeuropathyUnited States
-
The Hong Kong Polytechnic UniversityUnknown
-
University of SevilleAsociación de Enfermos de Parkinson de SevillaNot yet recruiting
-
Taipei Medical UniversityTaipei Medical University WanFang HospitalRecruitingCOPD | Vibration Therapy | COPD Chronic Obstructive Pulmonary DiseaseTaiwan
-
The Hong Kong Polytechnic UniversityThe University of Hong Kong; Manchester Metropolitan UniversityTerminatedSpinal Muscular Atrophy Type 3Hong Kong
-
The Hong Kong Polytechnic UniversityCompleted
-
Children's Hospital of Eastern OntarioCompletedDuchenne Muscular DystrophyCanada
-
Medway NHS Foundation TrustCompletedUrinary Stress IncontinenceUnited Kingdom